http://bmctoday.net/crstoday/ The latest news stories from Cataract & Refractive Surgery Today. en-us Sun, 14 Mar 2010 22:54:17 GMT Sun, 14 Mar 2010 22:54:17 GMT BMCToday http://bmctoday.net/crstoday/2010/02/article.asp?f=novartis-raises-its-stake-in-the-fast-growing-eye-care-business In a move to diversify its business and gain ground in the rapidly growing global eye care business, Novartis AG (Basel, Switzerland) announced in January a deal to purchase a majority stake in Alcon, Inc. (Huenenberg, Switzerland). Novartis said it would pay $28.1 billion for a majority stake in Alcon, with plans to acquire the rest of the s... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/02/article.asp?f=novartis-raises-its-stake-in-the-fast-growing-eye-care-business http://bmctoday.net/crstoday/2010/02/article.asp?f=bausch-+-lomb-introduces-the-crystalens-aspheric-optic-ao-lens Bausch + Lomb (Rochester, NY) announced the worldwide launch of its Crystalens Aspheric Optic (AO) IOL. The Crystalens AO was recently approved by the FDA and is the first aberration-free accommodating IOL with aspheric optics on the market. According to the company, the Crystalens AO has prolate aspheric surfaces and is designed to be free o... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/02/article.asp?f=bausch-+-lomb-introduces-the-crystalens-aspheric-optic-ao-lens http://bmctoday.net/crstoday/2010/02/article.asp?f=electronic-spectacles-to-debut-in-2010 PixelOptics, Inc. (Roanoke, VA), and Panasonic Shikoku Electronics Co., Ltd (Matsuyama, Japan), have collaborated on the development of PixelOptics’ electronic eyeglasses. PixelOptics announced its plan to market and sell both static (fixed focus) and electronic dynamic (changeable focus) lenses. PixelOptics launched atLast!, its first stati... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/02/article.asp?f=electronic-spectacles-to-debut-in-2010 http://bmctoday.net/crstoday/2010/02/article.asp?f=phase-23-trial-of-cataract-surgery-drug-initiated Icon Bioscience, Inc. (Sunnyvale, CA), has initiated a phase 2/3 pivotal clinical trial assessing the safety and efficacy of IBI-10090 in patients undergoing cataract surgery. IBI-10090 is a single-injection drug-delivery platform administered in the anterior chamber of the eye after cataract surgery. The agent reduces inflammation and aids r... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/02/article.asp?f=phase-23-trial-of-cataract-surgery-drug-initiated http://bmctoday.net/crstoday/2010/02/article.asp?f=funding-to-further-development-of-dry-eye-treatment EyeGate Pharmaceuticals, Inc. (Waltham, MA), said that it will use funding secured in series D venture financing to continue development of EGP-437, a dexamethasonederived corticosteroid solution, for the treatment of dry eye. EyeGate reportedly received $22.6 million, with $11 million available to the company in December 2009 and the remainin... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/02/article.asp?f=funding-to-further-development-of-dry-eye-treatment http://bmctoday.net/crstoday/2010/02/article.asp?f=production-resumed-after-limited-tecnis-1-piece-iol-recall Abbott Medical Optics, Inc. (Santa Ana, CA), announced a limited, voluntary recall of certain Tecnis 1-Piece IOLs this past November after receiving reports that the haptics had adhered to the lens’ optic during implantation. If the haptics stick, the surgeon may be required to use secondary surgical instruments to open them. Abbott said tha... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/02/article.asp?f=production-resumed-after-limited-tecnis-1-piece-iol-recall http://bmctoday.net/crstoday/2010/02/article.asp?f=risk-factors-affect-corneal-endothelial-cells-after-penetrating-keratoplasty Some risk factors contribute more than others to corneal endothelial cell loss after penetrating keratoplasty.1 Researchers at The Catholic University of Korea, Seoul, retrospectively evaluated the medical records of 83 eyes of 83 patients who had undergone penetrating keratoplasty and whose corneal endothelial cell density was more than 2,00... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/02/article.asp?f=risk-factors-affect-corneal-endothelial-cells-after-penetrating-keratoplasty http://bmctoday.net/crstoday/2010/02/article.asp?f=the-iop-lowering-effect-of-cataract-surgery According to research by Richard L. Lindstrom, MD, the founder of and an attending surgeon at Minnesota Eye Consultants, PA, in Minneapolis, cataract surgery alone may be able to lower IOP in patients with concurrent cataract and glaucoma. Dr. Lindstrom presented his results at the Royal Hawaiian Eye Meeting in Kauai. Dr. Lindstrom presented ... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/02/article.asp?f=the-iop-lowering-effect-of-cataract-surgery http://bmctoday.net/crstoday/2010/01/article.asp?f=lions-eye-institute-launches-ocular-research-center In October 2009, the Lions Eye Institute for Transplant and Research (LEITR) unveiled a 12,000-square-foot ocular research center in Tampa, Florida. LEITR is the world’s largest ocular research center and the first to be directly combined with an eye bank. This innovative model provides a repository of healthy and diseased ocular tissue to ... Sat, 2 Jan 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/01/article.asp?f=lions-eye-institute-launches-ocular-research-center http://bmctoday.net/crstoday/2010/01/article.asp?f=fda-seeks-additional-feedback-on-lasik-devices The FDA has reopened a public docket on LASIK devices. According to a news release, the goal is to collect additional information and improve outreach efforts regarding the safety and effectiveness of the devices. Previously open from September 12, 2008, through September 14, 2009, the docket is now available through November 15, 2010. â€... Sat, 2 Jan 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/01/article.asp?f=fda-seeks-additional-feedback-on-lasik-devices http://bmctoday.net/crstoday/2010/01/article.asp?f=alcon-to-enter-surgical-glaucoma-market Alcon, Inc. (Huenenberg, Switzerland), announced that it has entered into a definitive agreement to acquire Optonol, Ltd. (Neve Ilan, Israel), a medical device company that develops, manufactures, and markets miniature surgical implants used to lower IOP in patients with glaucoma. With this acquisition, Alcon will reportedly acquire Optonol’... Sat, 2 Jan 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/01/article.asp?f=alcon-to-enter-surgical-glaucoma-market http://bmctoday.net/crstoday/2010/01/article.asp?f=wavetec-reports-successful-use-of-orange-intraoperative-wavefront-aberrometer WaveTec Vision Systems, Inc. (Aliso Viejo, CA), announced that it has successfully used its ORange Intraoperative Wavefront Aberrometer to measure the refractive power of aphakic eyes. The company reportedly used the device to obtain aphakic measurements in more than 100 normal eyes at six separate sites in the United States. WaveTec stat... Sat, 2 Jan 2010 04:00:00 GMT http://bmctoday.net/crstoday/2010/01/article.asp?f=wavetec-reports-successful-use-of-orange-intraoperative-wavefront-aberrometer